89P Comprehensive genomic profiling of circulating tumor DNA for treatment recommendation: A sub-project of the IMPRESS-Norway trial von Dyvik, I., Fagereng, L., Lien, T., Nygaard, V., Silwal-Pandit, L., Noone, J.C., Wennerström, A.B., Skjulsvik, A.J., Ersland, K.M., Guren, T.K.K., Puco, K., Brabrand, S., Blix, E.S., Flobak, A., Haug, A., Johansson, K.A.M., Smeland, S., Tasken, K., Helland, A., Russnes, H.E.G.

Volltext

344P Tumor organoids from multifocal metastatic colorectal cancers for personalized oncology von Kryeziu, K., Berg, K.C.G., Totland, M.Z., Moosavi, S.H., Niederdorfer, B., Klokkerud, S.K., Bergsland, C.H., Guren, T.K.K., Lassen, K., Nesbakken, A., Yaqub, S., Sveen, A., Lothe, R.A.

Volltext

1235P Enrichment of rare cancers in pragmatic precision cancer medicine trial: Experience from IMPRESS-Norway von Helland, A., Hjortland, G.O., Fagereng, L., Bjorge, L., Gilje, B., Cameron, M.G., Donnem, T., Flobak, A., Fluge, S., Nguyen, O.T.D., Mannsåker, B., Stensvold, A., Russnes, H.E.G., Bjørgo, E., Guren, T.K.K., Smeland, S., Tasken, K.

Volltext

706P The IMPRESS-Norway trial: Improving public cancer care by implementing precision cancer medicine in Norway - Safety analysis of the first 126 patients included in the trial von Puco, K., Samdal Steinskog, E.S., Blix, E.S., Brabrand, S., Colban, M., Fagereng, L., Flobak, A., Fredvik Torkildsen, C., Guren, T.K.K., Haug, A., Johansson, K.A.M., Meltzer, S., Niehusmann, P., Oppedal, I.A., Russnes, H.E.G., Tasken, K., Smeland, S., Helland, A.

Volltext

1315O Key learnings from building: A precision cancer medicine implementation initiative for Norway von Tasken, K., Russnes, H.G., Aas, E., Bjorge, L., Blix, E.S., Enerly, E., Fagereng, L., Flobak, Å., Gilje, B., Gjertsen, B.T., Guren, T.K.K., Heix, J., Hovig, E., Hovland, R., Lonning, P.E., Mæhle, P.M., Nilsen, H.L., Thoresen, S., Smeland, S., Helland, A.

Volltext